• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. TRIGLYCERIDES_2 REAGENT, CONCENTRATED; TRIGLYCERIDE_2 REAGENTS, CONCENTRATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. TRIGLYCERIDES_2 REAGENT, CONCENTRATED; TRIGLYCERIDE_2 REAGENTS, CONCENTRATED Back to Search Results
Model Number TRIGLYCERIDES_2 REAGENT, CONCENTRATED
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/17/2014
Event Type  malfunction  
Event Description
Siemens technical assay specialist (tas) during troubleshooting at the customer site carried out a correlation using seven high patient samples, between the triglycerides_2 concentrated (trig_c) assay and the triglycerides_2 assay on an advia chemistry 1800 instrument.Based on the results obtained tas noticed that the high samples showed a low bias with the trig_c assay when using reagent lot 300275.It is unknown if any of the results obtained on the advia chemistry 1800 were reported to physician(s) there were no reports of adverse health consequences due to the results obtained for trig_c on the patient samples.
 
Manufacturer Narrative
Siemens has confirmed a low bias at the higher end of the triglyceride assay range on patient, quality control (qc), and linearity samples of advia chemistry trig_c reagent lot 300275 compared to alternate in date lots of trig_c, trig and trig_2 reagents.During siemens investigation, the trig_c reagent lot 300275 displayed a low bias that exceeded 25% at levels greater than approximately 425mg/dl for patients and quality controls.A positive (high) bias of approximately +10% was observed in qc samples at values less than 100mg/dl.The low bias occurred just prior to expiration of the affected kit lot 300275.Siemens diagnostics is investigating this issue.
 
Manufacturer Narrative
The initial mdr 2432235-2015-00230 was filed on may 15, 2015.Additional information (05/06/15): an actual root cause has not been established as the affected lot has expired.The current lots are being monitored for linearity on a monthly basis until the end of shelf life.
 
Manufacturer Narrative
The initial mdr 2432235-2015-00230 was filed on may 15, 2015.Supplemental mdr 2432235-2015-00230_s1 was filed on june 1, 2015.Additional information (07/13/15): the root cause of the low bias at the higher end of the triglyceride assay range on patient, quality control (qc), and linearity samples of advia chemistry trig_c reagent lot 300275 was determined to be a lower concentration of glycerokinase (gk) enzyme.The affected trig_c reagent lot 300275 expired on 12/31/2014.The customer has moved on to another lot that is unaffected.
 
Manufacturer Narrative
The initial mdr 2432235-2015-00230 was filed on may 15, 2015.Supplemental mdr 2432235-2015-00230_s1 was filed on june 1, 2015.Supplemental mdr 2432235-2015-00230_s2 was filed on august 12, 2015.Additional information (1/20/2016): during the process of monitoring all current lots siemens technical operations has confirmed that the trig_c assay reagent lot 338040 which was being monitored through end of shelf life is not linear to the instructions for use (ifu) claim of 550 mg/dl (62.15 mmol/l).Siemens diagnostics is investigating this issue.
 
Manufacturer Narrative
The initial mdr 2432235-2015-00230 was filed on may 14, 2015.Supplemental mdr 2432235-2015-00230_s1 was filed on june 1, 2015.Supplemental mdr 2432235-2015-00230_s2 was filed on august 12, 2015.Supplemental mdr 2432235-2015-00230_s3 was filed on february 9, 2016.Correction: supplemental mdr #3 states the date of awareness as 01/20/2016.The correct date is 01/13/2016.Additional information (2/29/2016): siemens could not conduct an investigation on trig_c reagent lot 300275 as it had expired.In date reagent lots 348297 and 359932 were monitored and based on internal studies siemens has confirmed that the two lots do not meet linearity claims as indicated in the instructions for use (ifu) of the assay.An urgent field safety notice (ufsn) chc16-03.A.Ous was sent to ous customers and a urgent medical device recall (umdr) chc16-03.A.Us was sent to us customers in march of 2016 to address reagent kit lots 348297 and 359932 only.Lot 300275 is expired and not part of this recall.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIGLYCERIDES_2 REAGENT, CONCENTRATED
Type of Device
TRIGLYCERIDE_2 REAGENTS, CONCENTRATED
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict avenue
tarrytown NY 10591
Manufacturer (Section G)
RANDOX LABORATORIES LTD. (REG# 8020890)
55 diamon road
crumlin
co. antrim, BT29 4QY
UK   BT29 4QY
Manufacturer Contact
aarti aziz
511 benedict avenue
tarrytown, NY 10591
9145242683
MDR Report Key4775495
MDR Text Key5782467
Report Number2432235-2015-00230
Device Sequence Number1
Product Code CDT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K133067
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,foreign,health profe
Reporter Occupation Health Professional
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup
Report Date 01/20/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model NumberTRIGLYCERIDES_2 REAGENT, CONCENTRATED
Device Catalogue Number10697575
Device Lot Number300275
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/06/2015
Initial Date FDA Received05/15/2015
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Supplement Dates FDA Received06/01/2015
02/09/2016
03/09/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number2432235-03/09/2016-001-R
Patient Sequence Number1
-
-